Name: Latest research reports of Aarti Drugs Ltd. authored by Axis Direct and published by - Trendlyne research reports.
Item: Aarti Drugs Ltd.
Rating: 5
Author: Axis Direct

Aarti Drugs Ltd.

NSE: AARTIDRUGS | BSE: 524348 | ISIN: INE767A01016 | Industry: Pharmaceuticals
| Value Stock, Under Radar

332.9000 -15.60 (-4.48%)

NSE Apr 04, 2025 15:31 PM

New 52W Low today

Volume: 286.1K

Aarti Drugs Ltd.

25 Jul 2023

332.90

-4.48%

Result Update:Aarti Drugs

Buy: Aarti Drugs Ltd.

Target

Axis Direct

We believe that Aarti Drugs, being a leader in the domestic industry, is well-placed to capitalize on prevalent as well as future growth opportunities. We have BUY rating on stock.

Aarti Drugs Ltd. has lost -26.59% in the last 3 Months